Brief: Alzinova Announces Positive Safety Review And Continuation Of Its Phase 1B Study In Alzheimer's Disease

Alzinova AB

28/04/2022 07:18

April 28 (Reuters) - Alzinova AB  ALZ.ST :
    * ALZINOVA ANNOUNCES POSITIVE SAFETY REVIEW AND CONTINUATION
OF
ITS PHASE 1B STUDY IN ALZHEIMER'S DISEASE
    * ALZINOVA AB - DATA AND SAFETY MONITORING BOARD (DSMB)
COMPLETED
A PLANNED ASSESSMENT OF ONGOING ALZ-101 PHASE 1B CLINICAL STUDY
AND RECOMMENDED CONTINUATION OF STUDY

Source text for Eikon:  ID:nWkr9z0kZh 
Further company coverage:  ALZ.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))